MedPath

Effect of vitamin D supplement in pregnancy on prevention of postpartum depressio

Phase 3
Conditions
postpartum depression.
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
F-53.0
Registration Number
IRCT2015020310327N11
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
148
Inclusion Criteria

willingness to participate in the study; aged 18 years or older; at 26- 28 weeks gestation based on ultrasound; alive and singleton fetus; without a history of cesarean section; without a history of any disease; free of complication in present pregnancy; Exclusion criteria:the score of Edinburgh Postnatal Depression Scale at beginning of the study is more than 13; cancellation of continuing the cooperation by the participants; less than 8 weeks taking vitamin D supplements or placebo

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postpartum depression. Timepoint: Four and eight weeks after delivery. Method of measurement: Edinburgh Postnatal Depression Scale.
Secondary Outcome Measures
NameTimeMethod
Serum 25-hydroxy vitamin D concentration. Timepoint: Before starting the interventions and at delivery. Method of measurement: Alisa or HPLC method.;Late pregnancy depression. Timepoint: at 38- 40 weeks gestation. Method of measurement: Edinburgh Postnatal Depression Scale.
© Copyright 2025. All Rights Reserved by MedPath